Identification of a novel mammalian post-translational modification, phosphocholine, on placental secretory polypeptides
Lovell, T. M., Woods, R. J., Butlin, D. J., Brayley, K. J., Manyonda, I. T., Jarvis, J., Howell, S. and Lowry, P. J. (2007) Identification of a novel mammalian post-translational modification, phosphocholine, on placental secretory polypeptides. Journal of Molecular Endocrinology, 39 (3-4). pp. 189-198. ISSN 0952-5041
Full text not archived in this repository.
To link to this article DOI: 10.1677/jme-07-0007
Placental neurokinin B appears to be post-translationally modified by phosphocholine (PC) attached to the aspartyl side chain at residue 4 of the mature peptide. Corticotrophin releasing factor (CRF) was found to be expressed by the rat placenta with the main secreted forms being phosphocholinated proCRF+/- one or two polysaccharide moieties. A combination of high-pressure liquid chromatography (HPLC) and two-site immunometric analysis suggested that PC was also attached to the placental precursors of adrenocorticotrophin, hemokinin, activin and follistatin. However, the fully processed forms of rat placental activin and CRF were free of PC. Formerly, the parasitic filarial nematodes have used PC as a post-translational modification, attached via the polysaccharicle moiety of certain secretory glycoproteins to attenuate the host immune system allowing parasite survival, but it is the PC group itself which endows the carrier with the biological activity. The fact that treatment of proCRF peptides with phospholipase C but not endoglycosidase destroyed PC immunoreactivity suggested a simpler mode of attachment of PC to placental peptides than that used by nematodes. Thus, it is possible that by analogy the placenta uses its secreted phosphocholinated hormones to modulate the mother's immune system and help protect the placenta from rejection.
Centaur Editors: Update this record